Dr. Craig Crews of the Crews Laboratory at Yale University describes his discovery and development of carfilzomib (Kyprolis) and what it takes to get a new drug across the

Dr. James R. Berenson discusses his use of myeloma therapies in a variety of combinations to target myeloma but to also address quality of life issues

Dr. Bensinger discusses a wide variety of new approaches to treatment including monoclonal antibody studies, new oral proteasome inhibitor studies, combinations with and without transplants, and the pros and cons of allo vs. auto transplantation

Dr. Benson describes how immunotherapy and NK cells work, and why most cancers are genetic or molecular diseases and not anatomical diseases

Dr. Robert A. Kyle discusses the history of myeloma innovation and the key elements needed to drive towards a cure

Dr. C. Ola Landgren discusses the importance and availability of new, more accurate diagnostic testing, and his detailed work in MGUS and smoldering myeloma

Dr. Don Benson discusses the benefits of participating in a clinical trial

Dr. Guido Tricot discusses myeloma stem cell research and published results of clinical trials

Dr. Robert Z. Orlowski discusses immunotherapies, early smoldering myeloma treatment and clinical trials